Get the tools used by (smart)2 investors.
Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

AMRX: Amneal Pharmaceuticals Inc Class A

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products wor...

7.42 USD
Price
USD
Fair Value
Upside
5.59 - 9.47
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Amneal Pharmaceuticals Inc Class A's Beneish M-Score:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 2024-3.00-2.00-1.000.001.00

Performance Summary
  • Amneal Pharmaceuticals's latest twelve months beneish m-score is -2.85
  • Amneal Pharmaceuticals's beneish m-score for fiscal years ending December 2020 to 2024 averaged -2.86.
  • Amneal Pharmaceuticals's operated at median beneish m-score of -2.82 from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Amneal Pharmaceuticals's beneish m-score peaked in December 2022 at -2.60.
  • Amneal Pharmaceuticals's beneish m-score hit its 5-year low in December 2023 of -3.25.
  • Amneal Pharmaceuticals's beneish m-score decreased in 2020 (-2.82, +4.8%) and 2023 (-3.25, +25.3%) and increased in 2021 (-2.80, -0.9%), 2022 (-2.60, -7.1%), and 2024 (-2.85, -12.4%).

Benchmarks

Metric Usage: Beneish M-Score

Hide this widget
beneish_mscore
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Beneish M-Score in the risk category include:

  • Current Ratio - A ratio that compares a company's current total assets to its current total liabilities.
  • Total Debt / FCF - A ratio that is calculated as Total Debt (including Capital Leases) divided by levered free cash flow.
  • Interest Coverage Ratio - A ratio used to assess a firm's ability to pay interest expenses based on operating profits (EBIT).
  • EBITDA Interest Coverage Ratio - A ratio used to assess a firm's ability to pay interest expenses based on EBITDA.
View Full List

Search for metric or datapoint

Beneish M-Score

A statistical score that uses financial ratios to identify whether a company has manipulated its earnings

Definition of Beneish M-Score

Hide this widget

The Beneish M-Score statistical score that uses financial ratios to identify whether a company has manipulated its earnings. Amneal Pharmaceuticals’s Beneish M-Score of −2.85 implies the company is not a likely earnings manipulator.

The Beneish M-Score outlines eight financial ratios required to calculate the score:

1) Days Sales in Receivables Index (DSRI)

DSRI = (Net Receivablest / Salest) / (Net Receivablest-1 / Salest-1)

2) Gross Margin Index (GMI)

GMI = [(Salest-1 - COGSt-1) / Salest-1] / [(Salest - COGSt) / Salest]

3) Asset Quality Index (AQI)

AQI = [(Total Assets - Current Assetst - PP&Et) / Total Assetst] / [(Total Assets - Current Assetst-1 - PP&Et-1) / Total Assetst-1]

4) Sales Growth Index (SGI)

SGI = Salest / Salest-1

5) Depreciation Index (DEPI)

DEPI = (Depreciationt-1/ (PP&Et-1 + Depreciationt-1)) / (Depreciationt / (PP&Et + Depreciationt))

6) Sales General and Administrative Expenses Index (SGAI)

SGAI = (SG&A Expenset / Salest) / (SG&A Expenset-1 / Salest-1)

7) Leverage Index (LVGI)

LVGI = [(Current Liabilitiest + Total Long Term Debtt) / Total Assetst] / [(Current Liabilitiest-1 + Total Long Term Debtt-1) / Total Assetst-1]

8) Total Accruals to Total Assets (TATA)

TATA = (Income from Continuing Operationst - Cash Flows from Operationst) / Total Assetst

After computing the eight variables outlined above, they can be weighted together using the following multivariate model to calculate the score:

Beneish M-Score =
-4.84
(+) 0.92 × DSRI
(+) 0.528 × GMI
(+) 0.404 × AQI
(+) 0.892 × SGI
(+) 0.115 × DEPI
(+) -0.172 × SGAI
(+) 4.679 × TATA
(+) -0.327 × LVGI

Click the link below to download a spreadsheet with an example Beneish M-Score calculation for Amneal Pharmaceuticals Inc Class A below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-17.58-2.5812.4230.130200400600

The chart above depicts the distribution of beneish m-score for companies operating in the Healthcare sector in the Developed economic region. Over 1,500 companies were considered in this analysis, and 1,448 had meaningful values. The average beneish m-score of companies in the sector is -2.42 with a standard deviation of 3.98.

Amneal Pharmaceuticals Inc Class A's Beneish M-Score of -2.85 ranks in the 40.2% percentile for the sector. The following table provides additional summary stats:

Beneish M-Score In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,508
Included Constituents1,448
Min-17.54
Max29.88
Median-2.71
Mean-2.42
Standard Deviation3.98

You can find companies with similar beneish m-score using this stock screener.

All rights reserved. Terms Of Use